Shu C Lin

US Patent:

6643332, Nov 4, 2003

Filed:

Jul 9, 1999

Appl. No.:

09/350700

Inventors:

Robert Morelos-Zaragoza - Sunnyvale CA
Shu Lin - Honolulu HI
Marc Fossorier - Honolulu HI

Assignee:

LSI Logic Corporation - Milpitas CA

International Classification:

H04L 2302

US Classification:

375265

Abstract:

A method and apparatus for multi-level encrypted encoding and decoding of digital signals, which includes utilizing only one type of encoder and one type of decoder. This can be either the same encoder and decoder used in throughout the process, or multiple, identical encoders and decoders. This allows the system to compensate for atmospheric degradation with higher bandwidth efficiency and a simplified receiver structure. The invention further identifies a 2 symbol generation technique that maps in disjoint regions of X-dimensional space, which allows different data bits to be eliminated from the decoding scheme and maximizes the number of independent data substreams that can be maintained.

US Patent:

20220354860, Nov 10, 2022

Filed:

Jun 15, 2020

Appl. No.:

17/596674

Inventors:

- Chongqing, CN
- Shanghai, CN
Yue RONG - Chongqing, CN
Ling CHEN - Chongqing, CN
Zhifang CHEN - Chongqing, CN
Rui TAN - Chongqing, CN
Lijun YANG - Chongqing, CN
Xianlong WANG - Chongqing, CN
Haohan TAN - Chongqing, CN
Bin LIU - Chongqing, CN
Chenglin ZHOU - Chongqing, CN
Yuwei GAO - Chongqing, CN
Lihua JIANG - Chongqing, CN
Shu LIN - San Leandro CA, US
Xingdong ZHAO - Chongqing, CN
Weibo WANG - Moraga CA, US

International Classification:

A61K 31/5383
C07D 498/04
C07D 471/04
C07D 513/04
A61K 31/437
A61K 31/542

Abstract:

Provided are certain URAT1 inhibitors, pharmaceutical compositions thereof, and methods of use thereof.

US Patent:

20220235049, Jul 28, 2022

Filed:

Jun 1, 2020

Appl. No.:

17/615420

Inventors:

- Chongqing, CN
- Shanghai, CN
Bin LIU - Chongqing, CN
Zhifu LI - Chongqing, CN
Xianlong WANG - Chongqing, CN
Zuwen ZHOU - Chongqing, CN
Weipeng ZHANG - Chongqing, CN
Yunling WANG - Chongqing, CN
Chenglin ZHOU - Chongqing, CN
Yuwei GAO - Chongqing, CN
Lihua JIANG - Chongqing, CN
Yanxin LIU - Chongqing, CN
Zongyao ZOU - Chongqing, CN
Shu LIN - San Leandro CA, US
Kai YU - San Leandro CA, US
Xingdong ZHAO - Chongqing, CN
Weibo WANG - Moraga CA, US

International Classification:

C07D 471/04

Abstract:

Provided are certain BTK inhibitors, pharmaceutical compositions thereof, and methods of use thereof.

US Patent:

20210139506, May 13, 2021

Filed:

Mar 27, 2019

Appl. No.:

17/042385

Inventors:

- Chongqing, CN
- Shanghai, CN
Chengxi HE - Chongqing, CN
Weipeng ZHANG - Chongqing, CN
Rui TAN - Chongqing, CN
Bin LIU - Chongqing, CN
Hong FU - Chongqing, CN
Haohan TAN - Chongqing, CN
Lijun YANG - Chongqing, CN
Hongbin LIU - Chongqing, CN
Yunling WANG - Chongqing, CN
Yuwei GAO - Chongqing, CN
Zongyao ZOU - Chongqing, CN
Yanxin LIU - Chongqing, CN
Shu LIN - San Leandro CA, US
Xingdong ZHAO - Chongqing, CN
Weibo WANG - Moraga CA, US

Assignee:

Fochon Pharmaceuticals, Ltd. - Chongqing
Shanghai Fochon Pharmaceutical Co., LTD. - Shanghai

International Classification:

C07D 498/22
C07D 498/20
C07D 487/22
A61P 35/00

Abstract:

Provided are certain TRK inhibitors, pharmaceutical compositions thereof, and methods of use thereof.

US Patent:

20210070711, Mar 11, 2021

Filed:

Mar 22, 2019

Appl. No.:

17/040577

Inventors:

- Chongqing, CN
- Shanghai, CN
Yunling WANG - Chongqing, CN
Xingdong ZHAO - Chongqing, CN
Tao CHENG - Chongqing, CN
Shu LIN - San Leandro CA, US
Weibo WANG - Moraga CA, US

International Classification:

C07D 217/02
A61K 45/06
A61K 31/472
A61P 27/02

Abstract:

Provided are compounds of Formula (I), or pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising these compounds thereof, and use of these compounds in preparing drugs for inhibiting ROCK.

US Patent:

20210024528, Jan 28, 2021

Filed:

Mar 13, 2019

Appl. No.:

16/980487

Inventors:

- Chongqing, CN
- Shanghai, CN
Chengxi HE - Chongqing, CN
Xianlong WANG - Chongqing, CN
Qihong LIU - Chongqing, CN
Zhifu LI - Chongqing, CN
Zuwen ZHOU - Chongqing, CN
Yuwei GAO - Chongqing, CN
Lihua JIANG - Chongqing, CN
Li LINGHU - Chongqing, CN
Shu LIN - San Leandro CA, US
Xingdong ZHAO - Chongqing, CN
Weibo WANG - Moraga CA, US

International Classification:

C07D 487/04
C07D 519/00

Abstract:

Provided are certain TRK inhibitors, pharmaceutical compositions thereof, and methods of use thereof.

US Patent:

20200099394, Mar 26, 2020

Filed:

Sep 24, 2018

Appl. No.:

16/139471

Inventors:

- HSINCHU CITY, TW
YEN-CHIN LIAO - HSINCHU CITY, TW
SHU LIN - MILPITAS CA, US

International Classification:

H03M 13/11
H03M 13/15
H03M 13/00

Abstract:

A low-density parity-check code scaling method is disclosed. The method includes following steps: obtaining the original low-density parity-check matrix; forming the permutation matrices with the random row shift or the random column shift to the identity matrix; replacing the component codes by the permutation matrices and the all-zero matrix to form the extended low-density parity-check matrix; adjusting the code length and the code rate to form the global coupled low-density parity-check matrix; and outputting the global coupled low-density parity-check code.

US Patent:

20200067834, Feb 27, 2020

Filed:

Nov 4, 2019

Appl. No.:

16/673679

Inventors:

- Santa Clara CA, US
Shu Lin - San Jose CA, US

International Classification:

H04L 12/741

Abstract:

Stateful inspection and classification of packets is disclosed. For a first packet associated with a network traffic flow, a differentiated services header value (DSHV) is determined to associate with the first packet. The DSHV is used to perform a lookup of a quality of service treatment associated with the DSHV. The treatment is applied to the first packet. A determination is made, for a second packet associated with the network traffic flow, to associate a second DSHV with the second, where the second DSHV is different from the first DSHV.